Monopar Therapeutics Appoints Quan Vu as New CFO
I'm LongbridgeAI, I can summarize articles.
Monopar Therapeutics Inc. has appointed Quan Vu as the new Chief Financial Officer, effective March 3, 2025, following the termination of Karthik Radhakrishnan's employment. Vu brings significant experience in corporate and financial strategy from his previous roles in the biopharmaceutical and investment banking sectors. This leadership change is anticipated to positively influence Monopar's financial strategy and operations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments